Trial Profile
Fingolimod promotes regulatory phenotype and function in B-cells of multiple sclerosis patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Nov 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 23 Dec 2015 New trial record